Select Medical’s (SEM) “Sector Perform” Rating Reiterated at Royal Bank Of Canada

Royal Bank Of Canada reissued their sector perform rating on shares of Select Medical (NYSE:SEM) in a report issued on Tuesday, Marketbeat Ratings reports. Royal Bank Of Canada currently has a $16.50 price target on the health services provider’s stock, down from their prior price target of $19.00.

Several other analysts have also issued reports on the company. Zacks Research lowered Select Medical from a “hold” rating to a “strong sell” rating in a research note on Thursday, February 26th. Mizuho set a $17.00 price objective on Select Medical in a research note on Monday, November 3rd. Weiss Ratings raised shares of Select Medical from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, February 20th. Finally, Wall Street Zen upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a research note on Sunday, March 1st. Two research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $15.63.

Select Medical Trading Down 0.1%

Shares of Select Medical stock opened at $16.24 on Tuesday. The firm has a market cap of $2.01 billion, a PE ratio of 14.12, a P/E/G ratio of 0.92 and a beta of 1.22. Select Medical has a 1 year low of $11.65 and a 1 year high of $18.60. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.04 and a quick ratio of 1.04. The stock has a fifty day moving average price of $15.37 and a 200-day moving average price of $14.26.

Select Medical (NYSE:SEM) last posted its quarterly earnings results on Thursday, February 19th. The health services provider reported $0.16 earnings per share for the quarter, missing the consensus estimate of $0.23 by ($0.07). Select Medical had a net margin of 2.68% and a return on equity of 7.26%. The company had revenue of $1.40 billion for the quarter, compared to the consensus estimate of $1.36 billion. During the same quarter in the previous year, the company posted $0.18 EPS. Select Medical’s quarterly revenue was up 6.4% compared to the same quarter last year. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. Equities research analysts anticipate that Select Medical will post 1.17 EPS for the current year.

Select Medical Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, March 12th. Stockholders of record on Monday, March 2nd will be issued a $0.0625 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.25 annualized dividend and a dividend yield of 1.5%. Select Medical’s dividend payout ratio is presently 21.74%.

Select Medical announced that its Board of Directors has initiated a share buyback program on Thursday, February 19th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the health services provider to buy up to 49.5% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board believes its stock is undervalued.

Hedge Funds Weigh In On Select Medical

Institutional investors have recently added to or reduced their stakes in the business. Caitong International Asset Management Co. Ltd bought a new stake in shares of Select Medical during the 4th quarter valued at about $28,000. Beartown Capital Management LLC purchased a new stake in Select Medical in the fourth quarter valued at approximately $2,970,000. State of Tennessee Department of Treasury lifted its position in Select Medical by 33.2% during the fourth quarter. State of Tennessee Department of Treasury now owns 63,307 shares of the health services provider’s stock valued at $953,000 after purchasing an additional 15,787 shares during the last quarter. XTX Topco Ltd grew its stake in Select Medical by 394.2% in the 4th quarter. XTX Topco Ltd now owns 138,229 shares of the health services provider’s stock worth $2,053,000 after buying an additional 110,257 shares in the last quarter. Finally, nVerses Capital LLC bought a new position in shares of Select Medical in the 4th quarter worth $163,000. 89.48% of the stock is currently owned by institutional investors.

More Select Medical News

Here are the key news stories impacting Select Medical this week:

• Positive Sentiment: The March 4 trading reaction — shares jumped ~8.4% as traders bought ahead of expected delisting, signaling short‑term demand and liquidity around the deal. Select Medical (SEM) Soars 8.4%, Traders Snap up Shares Ahead of Delisting
• Positive Sentiment: Zacks notes the $16.50 take‑private price may be undervalued relative to some analyst targets, implying potential upside for shareholders who think bids or outcomes could improve. SEM’s $16.50 Take-Private Moment: Undervalued or Perfectly Timed?
• Neutral Sentiment: Royal Bank of Canada gave SEM a Sector Perform rating — a reiteration that suggests no near‑term conviction for outsized moves from the street. Select Medical (NYSE:SEM) Earns Sector Perform Rating from Royal Bank Of Canada
• Neutral Sentiment: Benchmark reaffirmed a “hold” on SEM, reflecting cautious analyst posture amid the pending transaction and mixed fundamentals. Benchmark Reaffirms Hold
• Neutral Sentiment: Recent quarterly results showed a modest EPS miss (Feb 19) but revenue beat and FY‑2026 guidance of $1.22–1.32 — investors should weigh fundamentals vs. takeover dynamics when valuing the $16.50 offer. Select Medical Stock & Earnings Summary
• Negative Sentiment: Kahn Swick & Foti announced an investigation into whether the sale price and process are adequate; such suits can delay closing, increase deal costs, or lead to renegotiation. Select Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process
• Negative Sentiment: Kaskela Law launched a separate probe into whether $16.50 is fair, increasing the chance of litigation or shareholder pushback that could affect timing and final consideration. SELECT MEDICAL STOCK ALERT: Kaskela Law Announces Investigation

About Select Medical

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.